Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Katayama, Akihiro ^a   Nakatsuka, Atsuko ^a   Eguchi, Jun ^a   Murakami, Kazutoshi ^a   Teshigawara, Sanae ^a   Kanzaki, Motoko ^a   Nunoue, Tomokazu ^a   Hida, Kazuyuki ^b   Wada, Nozomu ^a   Yasunaka, Tetsuya ^a   Ikeda, Fusao ^a   Takaki, Akinobu ^a   Yamamoto, Kazuhide ^a   Kiyonari, Hiroshi ^c,d   Makino, Hirofumi ^a   Wada, Jun ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION OKAYAMA MEDICAL CENTER   (Japan)

^c Animal Resource Development Unit   (Japan)

^d RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALNEXIN; EYE PROTEIN; GPNMB PROTEIN, HUMAN; GPNMB PROTEIN, MOUSE; GPNMB PROTEIN, RAT; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN BINDING;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEPATIC STELLATE CELL; LIVER; LIVER CIRRHOSIS; MACROPHAGE; MALE; METABOLISM; MOUSE; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; OBESITY; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL; TRANSGENIC MOUSE; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE, WHITE; ANIMALS; BIOMARKERS; CALNEXIN; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROTEIN BINDING; RATS, INBRED OLETF; RISK FACTORS; RNA, MESSENGER;

EID: 84947792731     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16920     Document Type: Article

References (51)

1. Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-95 (2004).
2. Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142, 1592-609 (2012).
3. Loomba, R. et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56, 943-51 (2012).
4. Wada, J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17, 327-33 (2008).
5. Dietrich, P. & Hellerbrand, C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol 28, 637-53 (2014).
6. Sutti, S. et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 59, 886-97 (2014).
7. Zhong, S., Xu, J., Li, P. & Tsukamoto, H. Caveosomal oxidative stress causes Src-p21ras activation and lysine 63 TRAF6 protein polyubiquitination in iron-induced M1 hepatic macrophage activation. J Biol Chem 287, 32078-84 (2012).
8. Pinzani, M. Pathophysiology of Liver Fibrosis. Dig Dis 33, 492-7 (2015).
9. Hida, K. et al. Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. J Lipid Res 41, 1615-22 (2000).
10. Hida, K. et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102, 10610-5 (2005).
11. Singh, M. et al. Functional roles of osteoactivin in normal and disease processes. Crit Rev Eukaryot Gene Expr 20, 341-57 (2010).
12. Selim, A. A. Osteoactivin bioinformatic analysis: prediction of novel functions, structural features, and modes of action. Med Sci Monit 15, MT19-33 (2009).
13. Rose, A. A. et al. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS One 5, e12093 (2010).
14. Furochi, H. et al. Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett 581, 5743-50 (2007).
15. Weterman, M. A. et al. Nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 60, 73-81 (1995).
16. Safadi, F. F. et al. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 84, 12-26 (2001).
17. Abdelmagid, S. M. et al. Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. Exp Cell Res 314, 2334-51 (2008).
18. Singh, M., Del Carpio-Cano, F. E., Monroy, M. A., Popoff, S. N. & Safadi, F. F. Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts. J Cell Physiol 227, 390-9 (2012).
19. Anderson, M. G. et al. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol 4, 20 (2006).
20. Anderson, M. G. et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 30, 81-5 (2002).
21. Rose, A. A. et al. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin Cancer Res 16, 2147-56 (2010).
22. Shikano, S., Bonkobara, M., Zukas, P. K. & Ariizumi, K. Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J Biol Chem 276, 8125-34 (2001).
23. Chung, J. S., Sato, K., Dougherty, I. I., Cruz, P. D., Jr. & Ariizumi, K. DC-HIL is a negative regulator of T lymphocyte activation. Blood 109, 4320-7 (2007).
24. Bandari, P. S. et al. Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P. Regul Pept 111, 169-78 (2003).
25. Vaklavas, C. & Forero, A. Management of Metastatic Breast Cancer with Second-Generation Antibody-Drug Conjugates: Focus on Glembatumumab Vedotin (CDX-011, CR011-vcMMAE). BioDrugs 28, 253-63 (2014).
26. Ripoll, V. M., Irvine, K. M., Ravasi, T., Sweet, M. J. & Hume, D. A. Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol 178, 6557-66 (2007).
27. Tomihari, M., Chung, J. S., Akiyoshi, H., Cruz, P. D., Jr. & Ariizumi, K. DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res 70, 5778-87 (2010).
28. Chung, J. S., Bonkobara, M., Tomihari, M., Cruz, P. D., Jr. & Ariizumi, K. The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses. Eur J Immunol 39, 965-74 (2009).
29. Chung, J. S. et al. The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease. Immunology 138, 173-82 (2013).
30. Chung, J. S., Tamura, K., Akiyoshi, H., Cruz, P. D., Jr. & Ariizumi, K. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells. J Immunol 192, 2576-84 (2014).
31. Gabriel, T. L. et al. Lysosomal Stress in Obese Adipose Tissue Macrophages Contributes to MITF-Dependent Gpnmb Induction. Diabetes 63, 3310-23 (2014).
32. Haralanova-Ilieva, B., Ramadori, G. & Armbrust, T. Expression of osteoactivin in rat and human liver and isolated rat liver cells. J Hepatol 42, 565-72 (2005).
33. Onaga, M. et al. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol 39, 779-85 (2003).
34. Abe, H. et al. Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats. Biochem Biophys Res Commun 356, 610-5 (2007).
35. Tanaka, H. et al. The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep 2, 573 (2012).
36. Nakano, Y. et al. Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia-reperfusion injury. Neuroscience 277, 123-31 (2014).
37. Zhu, Y. et al. Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic reticulum stress-mediated apoptosis. Life Sci 94, 37-44 (2014).
38. Hernandez-Gea, V. et al. Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J Hepatol 59, 98-104 (2013).
39. De Minicis, S. et al. Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution. Liver Int 32, 1574-84 (2012).
40. Lim, M. P., Devi, L. A. & Rozenfeld, R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis 2, e170 (2011).
41. Okazaki, Y., Ohno, H., Takase, K., Ochiai, T. & Saito, T. Cell surface expression of calnexin, a molecular chaperone in the endoplasmic reticulum. J Biol Chem 275, 35751-8 (2000).
42. Wiest, D. L., Burgess, W. H., McKean, D., Kearse, K. P. & Singer, A. The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype-independent CD3 complexes. EMBO J 14, 3425-33 (1995).
43. Itakura, M., Tsujimura, J., Yamamori, S., Ohkido, T. & Takahashi, M. NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membrane. Neurosci Lett 550, 173-8 (2013).
44. Rose, A. A. et al. Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res 5, 1001-14 (2007).
45. Rich, J. N. et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278, 15951-7 (2003).
46. Rose, A. A. & Siegel, P. M. Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer? Breast Cancer Res 9, 403 (2007).
47. Joost, H. G. & Schurmann, A. Subcellular fractionation of adipocytes and 3T3-L1 cells. Methods Mol Biol 155, 77-82 (2001).
48. Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413-9 (1999).
49. Brunt, E. M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21, 3-16 (2001).
50. Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-21 (2005).
51. Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. & Bacon, B. R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94, 2467-74 (1999).